Since 2010 VivoSense has been helping clinical researchers analyze and interpret wearable sensor data to improve patient research and care. Following our $25M Series A Financing in March 2022, we are on the fast track to adding passionate and motivated team members!
VivoSense is committed to the development of better medicines and medical interventions for improved patient outcomes.
Guided by scientific principles, applying leading-edge methodologies with accuracy, academic transparency within the regulated framework required by our industry.
VivoSense never tells the customer anything but the scientific truth, never promising what cannot be delivered.
VivoSense is committed to diversity and inclusion, where every voice is heard and the best-reasoned facts are those acted upon.
VivoSense strives for a minimal environmental impact, printing documents and traveling for business only when necessary.
VivoSense recognizes the balance in work and family and provides for a flexible schedule, encouraging telecommuting whenever possible and minimizing the need for commuting at all times.
“My work as a scientist building trusted digital clinical measures is incredibly rewarding as I can see clearly how they have the potential to improve clinical research and healthcare. I’m lucky that I get to work with a team of phenomenally talented, dedicated, and motivated people to make it happen.”
~ Jen Blankenship, PhD, VivoSense Clinical Scientist